Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are very common in people with end-stage kidney disease.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The most common skin problems in Indian children are infections and eczemas.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Both mouse and rat models are effective for testing alopecia areata treatments.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Testosterone may slow down wound healing and increase inflammation.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Early balding linked to higher heart disease risk.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Treating cystoid macular oedema in uveitis is difficult and risky.